Clinical Trial Update: Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Cyberknife radiosurgery boost for hilar cholangiocarcinoma (Klatskin tumor) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Cholangiocarcinoma, Klatskin Tumor | Phase 1 | Status: TERMINATED